-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$293.15-7.23% Downside
Recent Analyst Forecasts and Stock Ratings
Amgen Inc. Frequently Asked Questions
-
What analysts cover Amgen Inc.?
Amgen Inc. has been rated by research analysts at Morgan Stanley, Goldman Sachs, Barclays, BMO Capital, Raymond James, Robert W. Baird in the past 90 days.